NR3C2 and coronary artery disorder: The patient reported no history of coronary artery disease (CAD) and remained symptomatic for dyspnea on mild exertion (NYHA class III) despite optimal medical therapy (OMT) with beta-blockers, angiotensin receptor-neprilysin inhibitor (ARNi), mineralocorticoid receptor antagonist (MRA), loop diuretics plus device therapy with implantable cardioverter-defibrillator (ICD), and cardiac resynchronization therapy (CRT).